InvestorsHub Logo
Followers 185
Posts 2462
Boards Moderated 0
Alias Born 02/10/2017

Re: None

Tuesday, 02/26/2019 7:33:01 AM

Tuesday, February 26, 2019 7:33:01 AM

Post# of 9998
James Hodgins, chief investment officer at Curvature Hedge Strategies, discusses InMed Pharmaceuticals. 3 days ago

https://www.bnnbloomberg.ca/investing/video/james-hodgins-discusses-inmed-pharmaceuticals~1394817


IMLFF scaling up Bio Synthesis when this is complete later this year IMLFF will be off to new 52 week highs and depending on partnerships and revenue for Bio Synthesis this could be 10.00+ within a year.
Life changing money.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent INM News